| The TREAT‐NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations CL Bladen, D Salgado, S Monges, ME Foncuberta, K Kekou, K Kosma, ... Human mutation 36 (4), 395-402, 2015 | 770 | 2015 |
| Segregation of leading-edge and uropod components into specific lipid rafts during T cell polarization C Gómez-Moutón, JL Abad, E Mira, RA Lacalle, E Gallardo, ... Proceedings of the National Academy of Sciences 98 (17), 9642-9647, 2001 | 586 | 2001 |
| Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg L Querol, G Nogales-Gadea, R Rojas-Garcia, J Diaz-Manera, J Pardo, ... Neurology 82 (10), 879-886, 2014 | 379 | 2014 |
| Long-lasting treatment effect of rituximab in MuSK myasthenia J Díaz-Manera, E Martínez-Hernández, L Querol, R Klooster, ... Neurology 78 (3), 189-193, 2012 | 379 | 2012 |
| Antibodies to contactin‐1 in chronic inflammatory demyelinating polyneuropathy L Querol, G Nogales‐Gadea, R Rojas‐Garcia, E Martinez‐Hernandez, ... Annals of neurology 73 (3), 370-380, 2013 | 377 | 2013 |
| Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype I Illa, C Serrano‐Munuera, E Gallardo, A Lasa, R Rojas‐García, J Palmer, ... Annals of Neurology: Official Journal of the American Neurological …, 2001 | 342 | 2001 |
| Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins L Querol, R Rojas-García, J Diaz-Manera, J Barcena, J Pardo, ... Neuroimmunology & Neuroinflammation 2 (5), e149, 2015 | 264 | 2015 |
| Inflammation in dysferlin myopathy: immunohistochemical characterization of 13 patients E Gallardo, R Rojas–García, N De Luna, A Pou, RH Brown Jr, I Illa Neurology 57 (11), 2136-2138, 2001 | 238 | 2001 |
| JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis L Ladislau, X Suárez-Calvet, S Toquet, O Landon-Cardinal, D Amelin, ... Brain 141 (6), 1609-1621, 2018 | 213 | 2018 |
| Acute axonal Guillain‐Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides I Illa, N Ortiz, E Gallard, C Juarez, JM Grau, MC Dalakas Annals of neurology 38 (2), 218-224, 1995 | 196 | 1995 |
| Clinical outcomes in Duchenne muscular dystrophy: a study of 5345 patients from the TREAT-NMD DMD global database Z Koeks, CL Bladen, D Salgado, E Van Zwet, O Pogoryelova, ... Journal of neuromuscular diseases 4 (4), 293-306, 2017 | 176 | 2017 |
| Muscle MRI in muscular dystrophies J Díaz-Manera, J Llauger, E Gallardo, I Illa Acta Myologica 34 (2-3), 95, 2015 | 160 | 2015 |
| Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo F Lluıs, J Roma, M Suelves, M Parra, G Aniorte, E Gallardo, I Illa, ... Blood, The Journal of the American Society of Hematology 97 (6), 1703-1711, 2001 | 157 | 2001 |
| Sustained response to Rituximab in anti-AChR and anti-MuSK positive Myasthenia Gravis patients I Illa, J Diaz-Manera, R Rojas-Garcia, J Pradas, A Rey, R Blesa, C Juarez, ... Journal of neuroimmunology 201, 90-94, 2008 | 156 | 2008 |
| Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies C Paradas, J Llauger, J Diaz-Manera, R Rojas-Garcia, N De Luna, ... Neurology 75 (4), 316-323, 2010 | 142 | 2010 |
| A novel, blood‐based diagnostic assay for limb girdle muscular dystrophy 2B and Miyoshi myopathy M Ho, E Gallardo, D McKenna‐Yasek, N De Luna, I Illa, RH Brown Jr Annals of Neurology: Official Journal of the American Neurological …, 2002 | 131 | 2002 |
| Fibroadipogenic progenitors are responsible for muscle loss in limb girdle muscular dystrophy 2B MW Hogarth, A Defour, C Lazarski, E Gallardo, J Diaz Manera, ... Nature communications 10 (1), 2430, 2019 | 128 | 2019 |
| Clinical and therapeutic features of myasthenia gravis in adults based on age at onset E Cortés-Vicente, R Álvarez-Velasco, S Segovia, C Paradas, ... Neurology 94 (11), e1171-e1180, 2020 | 126 | 2020 |
| Cortactin autoantibodies in myasthenia gravis E Gallardo, E Martínez-Hernández, MJ Titulaer, MG Huijbers, ... Autoimmunity reviews 13 (10), 1003-1007, 2014 | 125 | 2014 |
| Absence of dysferlin alters myogenin expression and delays human muscle differentiation “in vitro” N De Luna, E Gallardo, M Soriano, R Dominguez-Perles, C De La Torre, ... Journal of Biological Chemistry 281 (25), 17092-17098, 2006 | 125 | 2006 |
Xavi Suárez CalvetNeuromuscular Disorders Unit, Hospital de la Santa Creu i Sant Pau, Barcelona, SpainEmail verificata su santpau.cat
